In today's episode of Category Visionaries, we speak with David Berry, CEO and Founder of Valo, an AI for drug discovery and development company that's raised over $500 Million in funding.
Topics Discussed:
- David’s background in the healthcare space, and how getting bitten by the entrepreneurial bug led him away from a career in medicine
- Valo’s mission and their unique approach to developing new generations of drugs
- The immense cost and poor efficiency associated with the traditional approach to developing and discovering new medicine
- How data integration and AI technologies have supercharged the drug development process, and the prospects for innovation in the year to come
- Regulatory considerations and building a working relationship with the FDA
- Starting a unicorn company, and the challenges and responsibilities that come with it
Favorite book: